Artemin is oncogenic for human mammary carcinoma cells

Oncogene

Volumn 28, Issue 19, 2009, Pages 2034-2045

  Kang, J ^a   Perry, J K ^a   Pandey, V ^a   Fielder, G C ^a   Mei, B ^b,c   Qian, P X ^b   Wu, Z S ^c   Zhu, T ^b   Liu, D X ^a   Lobie, P E ^a,d  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Artemin; Carcinoma; GDNF; Mammary; Oncogenicity

Indexed keywords

ARTEMIN; PROTEIN ANTIBODY; SMALL INTERFERING RNA; ARTN PROTEIN, HUMAN; NERVE PROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INVASION; CANCER SIZE; CELL INVASION; CELL MIGRATION; COLONY FORMING UNIT; CONTROLLED STUDY; GENETIC DATABASE; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; GENE EXPRESSION REGULATION; METABOLISM; NUDE MOUSE; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NERVE TISSUE PROTEINS; TRANSPLANTATION, HETEROLOGOUS;

EID: 66149099338     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.66     Document Type: Article

References (43)

1. Airaksinen MS, Saarma M. (2002). The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3: 383-394.
2. Airaksinen MS, Titievsky A, Saarma M. (1999). GDNF family neurotrophic factor signaling: four masters, one servant? Mol Cell Neurosci 13: 313-325.
3. Anderson J, Ramsay A, Gould S, Pritchard-Jones K. (2001). PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma. Am J Pathol 159: 1089-1096.
4. Bespalov MM, Saarma M. (2007). GDNF family receptor complexes are emerging drug targets. Trends Pharmacol Sci 28: 68-74.
5. Brouty-Boye D, Raux H. (1993). Differential influence of stromal fibroblasts from different breast tissues on human breast tumour cell growth in nude mice. Anticancer Res 13: 1087-1090.
6. Ceyhan GO, Bergmann F, Kadihasanoglu M, Erkan M, Park W, Hinz U et al. (2007). The neurotrophic factor artemin influences the extent of neural damage and growth in chronic pancreatitis. Gut 56: 534-544.
7. Ceyhan GO, Giese NA, Erkan M, Kerscher AG, Wente MN, Giese T et al. (2006). The neurotrophic factor artemin promotes pancreatic cancer invasion. Ann Surg 244: 274-281.
8. Chung LW. (1993). Implications of stromal-epithelial interaction in human prostate cancer growth, progression and differentiation. Semin Cancer Biol 4: 183-192.
9. Duxbury MS, Matros E, Ito H, Zinner MJ, Ashley SW, Whang EE. (2004). Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer. Ann Surg 240: 667-674.
10. Enomoto H, Hughes I, Golden J, Baloh RH, Yonemura S, Heuckeroth RO et al. (2004). GFRα1 expression in cells lacking RET is dispensable for organogenesis and nerve regeneration. Neuron 44: 623-636.
11. Esseghir S, Todd SK, Hunt T, Poulsom R, Plaza-Menacho I, Reis-Filho JS et al. (2007). A role for glial cell derived neurotrophic factor induced expression by inflammatory cytokines and RET/ GFRα1 receptor up-regulation in breast cancer. Cancer Res 67: 11732-11741.
12. Hutcheson IR, Knowlden JM, Jones HE, Burmi RS, McClelland RA, Barrow D et al. (2006). Inductive mechanisms limiting response to anti-epidermal growth factor receptor therapy. Endocr Relat Cancer 13(Suppl 1): S89-S97.
13. Ichihara M, Murakumo Y, Takahashi M. (2004). RET and neuroendocrine tumors. Cancer Lett 204: 197-211.
14. Ito Y, Okada Y, Sato M, Sawai H, Funahashi H, Murase T et al. (2005). Expression of glial cell line-derived neurotrophic factor family members and their receptors in pancreatic cancers. Surgery 138: 788-794.
15. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. (1993). GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130-1132.
16. Liu DX, Lobie PE. (2007). Transcriptional activation of p53 by Pitx1. Cell Death Differ 14: 1893-1907.
17. Lubaroff DM, Canfield L, Reynolds CW. (1980). The Dunning tumors. Prog Clin Biol Res 37: 243-263.
18. Masure S, Geerts H, Cik M, Hoefnagel E, Van Den KG, Tuytelaars A et al. (1999). Enovin, a member of the glial cell-line-derived neurotrophic factor (GDNF) family with growth promoting activity on neuronal cells. Existence and tissue-specific expression of different splice variants. Eur J Biochem 266: 892-902.
19. Meng X, de Rooij DG, Westerdahl K, Saarma M, Sariola H. (2001a). Promotion of seminomatous tumors by targeted overexpression of glial cell line-derived neurotrophic factor in mouse testis. Cancer Res 61: 3267-3271.
20. Meng X, Lindahl M, Hyvonen ME, Parvinen M, de Rooij DG, Hess MW et al. (2000). Regulation of cell fate decision of undifferentiated spermatogonia by GDNF. Science 287: 1489-1493.
21. Meng X, Pata I, Pedrono E, Popsueva A, de Rooij DG, Janne M et al. (2001b). Transient disruption of spermatogenesis by deregulated expression of neurturin in testis. Mol Cell Endocrinol 184: 33-39.
22. Okada Y, Takeyama H, Sato M, Morikawa M, Sobue K, Asai K et al. (1999). Experimental implication of celiac ganglionotropic invasion of pancreatic-cancer cells bearing c-ret proto-oncogene with reference to glial-cell-line-derived neurotrophic factor (GDNF). Int J Cancer 81: 67-73.
23. Pandey V, Perry JK, Mohankumar KM, Kong XJ, Liu SM, Wu ZS et al. (2008). Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells. Endocrinology 149: 3909-3919.
24. Paratcha G, Ledda F, Ibanez CF. (2003). The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell 113: 867-879.
25. Pasini B, Ceccherini I, Romeo G. (1996). RET mutations in human disease. Trends Genet 12: 138-144.
26. Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ et al. (1996). Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 2: 1627-1636.
27. Popsueva A, Poteryaev D, Arighi E, Meng X, ngers-Loustau A, Kaplan D et al. (2003). GDNF promotes tubulogenesis of GFRα1-expressing MDCK cells by Src-mediated phosphorylation of Met receptor tyrosine kinase. J Cell Biol 161: 119-129.
28. Poteryaev D, Titievsky A, Sun YF, Thomas-Crusells J, Lindahl M, Billaud M et al. (1999). GDNF triggers a novel ret-independent Src kinase family-coupled signaling via a GPI-linked GDNF receptor α1. FEBS Lett 463: 63-66.
29. Saarma M, Sariola H. (1999). Other neurotrophic factors: glial cell line-derived neurotrophic factor (GDNF). Microsc Res Tech 45: 292-302.
30. Sadlonova A, Novak Z, Johnson MR, Bowe DB, Gault SR, Page GP et al. (2005). Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture. Breast Cancer Res 7: R46-R59.
31. Sariola H, Saarma M. (2003). Novel functions and signalling pathways for GDNF. J Cell Sci 116: 3855-3862.
32. Schueler-Furman O, Glick E, Segovia J, Linial M. (2006). Is GAS1 a co-receptor for the GDNF family of ligands? Trends Pharmacol Sci 27: 72-77.
33. Singh S, Sadanandam A, Singh RK. (2007). Chemokines in tumor angiogenesis and metastasis. Cancer Metastasis Rev 26: 453-467.
34. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S et al. (1998). The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 17: 5001-5014.
35. Su G, Blaine SA, Qiao D, Friedl A. (2007). Shedding of syndecan-1 by stromal fibroblasts stimulates human breast cancer cell proliferation via FGF2 activation. J Biol Chem 282: 14906-14915.
36. Takahashi M. (2001). The GDNF/RET signaling pathway and human diseases. Cytokine Growth Factor Rev 12: 361-373.
37. Trupp M, Scott R, Whittemore SR, Ibanez CF. (1999). Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells. J Biol Chem 274: 20885-20894.
38. Veit C, Genze F, Menke A, Hoeffert S, Gress TM, Gierschik P et al. (2004). Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells. Cancer Res 64: 5291-5300.
39. Wu K, Weng Z, Tao Q, Lin G, Wu X, Qian H et al. (2003). Stage-specific expression of breast cancer-specific gene γ-synuclein. Cancer Epidemiol Biomarkers Prev 12: 920-925.
40. Zhang P, Chan SL, Fu W, Mendoza M, Mattson MP. (2003). TERT suppresses apoptotis at a premitochondrial step by a mechanism requiring reverse transcriptase activity and 14-3-3 protein-binding ability. FASEB J 17: 767-769.
41. Zhu T, Starling-Emerald B, Zhang X, Lee KO, Gluckman PD, Mertani HC et al. (2005). Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone. Cancer Res 65: 317-324.
42. Zhu ZW, Friess H, Wang L, Bogardus T, Korc M, Kleeff J et al. (2001). Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells. Clin Cancer Res 7: 105-112.
43. Zinkel S, Gross A, Yang E. (2006). BCL2 family in DNA damage and cell cycle control. Cell Death Differ 13: 1351-1359.